JP2025502191A5 - - Google Patents

Info

Publication number
JP2025502191A5
JP2025502191A5 JP2024541745A JP2024541745A JP2025502191A5 JP 2025502191 A5 JP2025502191 A5 JP 2025502191A5 JP 2024541745 A JP2024541745 A JP 2024541745A JP 2024541745 A JP2024541745 A JP 2024541745A JP 2025502191 A5 JP2025502191 A5 JP 2025502191A5
Authority
JP
Japan
Application number
JP2024541745A
Other languages
Japanese (ja)
Other versions
JP2025502191A (ja
JPWO2023137403A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/060594 external-priority patent/WO2023137403A2/en
Publication of JP2025502191A publication Critical patent/JP2025502191A/ja
Publication of JP2025502191A5 publication Critical patent/JP2025502191A5/ja
Publication of JPWO2023137403A5 publication Critical patent/JPWO2023137403A5/ja
Pending legal-status Critical Current

Links

JP2024541745A 2022-01-12 2023-01-12 治療剤に結合したラルチトレキセドまたは5-mthfを含む化合物、組成物、および使用する方法 Pending JP2025502191A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263298793P 2022-01-12 2022-01-12
US63/298,793 2022-01-12
US202263299261P 2022-01-13 2022-01-13
US63/299,261 2022-01-13
PCT/US2023/060594 WO2023137403A2 (en) 2022-01-12 2023-01-12 Compound comprising raltitrexed or 5-mthf linked to a therapeutic agent, composition, and method of use

Publications (3)

Publication Number Publication Date
JP2025502191A JP2025502191A (ja) 2025-01-24
JP2025502191A5 true JP2025502191A5 (https=) 2026-01-27
JPWO2023137403A5 JPWO2023137403A5 (https=) 2026-01-27

Family

ID=87279733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541745A Pending JP2025502191A (ja) 2022-01-12 2023-01-12 治療剤に結合したラルチトレキセドまたは5-mthfを含む化合物、組成物、および使用する方法

Country Status (6)

Country Link
US (1) US20250222117A1 (https=)
EP (1) EP4463149A2 (https=)
JP (1) JP2025502191A (https=)
KR (1) KR20240150763A (https=)
CA (2) CA3248149A1 (https=)
WO (1) WO2023137403A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023230616A2 (en) * 2022-05-26 2023-11-30 Purdue Research Foundation Combination of small molecule drug conjugate and car-expressing cytotoxic lymphocytes and methods of use
WO2024186626A1 (en) * 2023-03-03 2024-09-12 Bolt Biotherapeutics, Inc. Aza-bicyclic sting agonist immunoconjugates, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL305483A (en) * 2018-03-20 2023-10-01 Dana Farber Cancer Inst Inc Preparations and methods for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2024501894A5 (https=)
JP2025502191A5 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BY13167U (https=)
BY13174U (https=)
CN307048853S (https=)
CN307048074S (https=)
CN307047568S (https=)
CN307046899S (https=)
CN307046210S (https=)
CN307046189S (https=)
CN307045700S (https=)
CN307045091S (https=)
CN307044610S (https=)
CN307044258S (https=)
BY23999C1 (https=)
BY13161U (https=)
BY13176U (https=)
BY13162U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
BY13172U (https=)